C4 Therapeutics Inc (CCCC): Gewinn- und Verlustrechnung
Kennzahl in 1000 USD | TTM 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
Umsatz | 35.039 | 35.947 | 35.584 | 20.756 | 31.096 | 45.785 | 33.195 | 21.381 | 19.364 |
Herstellungskosten | 3.607 | 7.975 | 7.894 | 7.737 | 7.572 | 2.907 | 78.440 | 47.664 | 28.592 |
Bruttoergebnis | 33.238 | 27.972 | 35.584 | 13.019 | 31.096 | 45.785 | -45.245 | 21.381 | -9.228 |
▸ Brutto-Marge | 94,86% | 77,81% | 100% | 62,72% | 100% | 100% | -136,3% | 100% | -47,66% |
Betriebliche Aufwendungen | 145.003 | 132.461 | 155.198 | 152.050 | 160.630 | 127.919 | 15.204 | 56.833 | 7.161 |
Operativer Gewinn/Verlust | -111.765 | -104.489 | -119.614 | -139.031 | -129.534 | -82.134 | -60.449 | -35.452 | -16.389 |
▸ Operative Marge | -318,97% | -290,68% | -336,15% | -669,84% | -416,56% | -179,39% | -182,1% | -165,81% | -84,64% |
Zinsen (Netto) | 10.470 | 10.349 | 14.429 | 7.198 | 1.359 | -1.758 | -836 | -325 | 685 |
▸ Zinsausgaben | - | - | - | 1.373 | 2.216 | 2.145 | 1.229 | 2.157 | - |
▸ Zinseinnahmen | 10.470 | 10.349 | 14.429 | 8.571 | 3.575 | 387 | 393 | 1.832 | 685 |
Andere Ausgaben | - | 10.733 | - | -620 | - | - | 4.423,999 | -2.482 | 7 |
Gewinn vor Steuern | -101.295 | -104.873 | -105.185 | -131.213 | -128.175 | -83.892 | -65.708,999 | -33.295 | -15.711 |
Steueraufwand | 121 | 121 | 131 | 1.280 | -1.676 | 2.145 | 626 | 804 | 678 |
Minderheitenanteil | - | - | - | - | 1.676 | -2.145 | - | - | -678 |
Nettogewinn/-verlust | -101.416 | -104.994 | -105.316 | -132.493 | -128.175 | -83.892 | -66.334,999 | -34.099 | -15.711 |
▸ Netto-Marge | -289,44% | -292,08% | -295,96% | -638,34% | -412,19% | -183,23% | -199,83% | -159,48% | -81,14% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.